Dexmedetomidine for modified electroconvulsive therapy: a dose-optimized treatment study

Dexmedetomidine for modified electroconvulsive therapy: a dose-optimized treatment study

Abstract Objectives To determine the optimal dexmedetomidine dose for hemodynamic stability and recovery quality in modified electroconvulsive therapy (MECT). Methods In this randomized trial, 252 patients receiving MECT were allocated to six groups (placebo, D1–D5; 42/group). Groups D1–D5 received...

Full description

Saved in:
Bibliographic Details
Main Authors: Jun Shen, Min Zhou, Guangliang Zhu, Yu Zhang, Jinzhi Ma, Dekui Li, Lei Chen, Kejun Qi, Anjiang Wang, Yang Jiang, Zhiming Dai, Xiaoming Li
Format: Article
Language:English
Published: BMC 2025-04-01
Series:European Journal of Medical Research
Subjects:
Dexmedetomidine
Modified electroconvulsive therapy
Anesthesia
Preconditioning
Optimal dose
Online Access:https://doi.org/10.1186/s40001-025-02509-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40001-025-02509-3

Similar Items